TABLE 3.
Basic clinical characteristics of KIRP patients in validation cohort.
| Characteristic | Levels | Overall |
|---|---|---|
| n | 30 | |
| Pathologic T stage, n (%) | T1 | 21 (70%) |
| T2 | 3 (10%) | |
| T3 | 3 (10%) | |
| T4 | 3 (10%) | |
| Pathologic N stage, n (%) | N0 | 18 (60%) |
| N1 | 9 (30%) | |
| N2 | 3 (10%) | |
| Pathologic M stage, n (%) | M0 | 27 (90%) |
| M1 | 3 (10%) | |
| Pathologic stage, n (%) | Stage I | 18 (60%) |
| Stage II | 3 (10%) | |
| Stage III | 6 (20%) | |
| Stage IV | 3 (10%) | |
| Gender, n (%) | Female | 9 (30%) |
| Male | 21 (70%) | |
| Age, n (%) | <=60 | 15 (50%) |
| >60 | 15 (50%) | |
| Age, median (IQR) | 62 (55, 70) |